FINWIRES · TerminalLIVE
FINWIRES

Mizuho Initiates Zentalis Pharmaceuticals at Outperform With $8 Price Target

By

Zentalis Pharmaceuticals (ZNTL) has an average rating of overweight and mean price target of $6.50, according to analysts polled by FactSet.

What else is happening in Research?